Multiorgan inflammatorisk syndrom hos barn og ungdom etter SARS-CoV-2-infeksjon
- 1.
Rubens JH, Akindele NP, Tschudy MM et al. Acute covid-19 and multisystem inflammatory syndrome in children. BMJ 2021; 372: n385. [PubMed][CrossRef]
- 2.
Riphagen S, Gomez X, Gonzalez-Martinez C et al. Hyperinflammatory shock in children during COVID-19 pandemic. Lancet 2020; 395: 1607–8. [PubMed][CrossRef]
- 3.
Verdoni L, Mazza A, Gervasoni A et al. An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study. Lancet 2020; 395: 1771–8. [PubMed][CrossRef]
- 4.
Hoste L, Van Paemel R, Haerynck F. Multisystem inflammatory syndrome in children related to COVID-19: a systematic review. Eur J Pediatr 2021; 180: 2019–34. [PubMed][CrossRef]
- 5.
Aronoff SC, Hall A, Del Vecchio MT. The natural history of SARS-Cov-2 related multisystem inflammatory syndrome in children (MIS-C): A systematic review. J Pediatric Infect Dis Soc 2020; 9: 746–51. [PubMed][CrossRef]
- 6.
Jiang L, Tang K, Levin M et al. COVID-19 and multisystem inflammatory syndrome in children and adolescents. Lancet Infect Dis 2020; 20: e276–88. [PubMed][CrossRef]
- 7.
Ahmed M, Advani S, Moreira A et al. Multisystem inflammatory syndrome in children: A systematic review. EClinicalMedicine 2020; 26: 100527. [PubMed][CrossRef]
- 8.
Royal College Paediatrics and Child Health. Guidance: Paediatric multisystem inflammatory syndrome temporally associated with COVID-19. https://www.rcpch.ac.uk/resources/guidance-paediatric-multisystem-inflammatory-syndrome-temporally-associated-covid-19 Lest 26.5.2020.
- 9.
Multisystem inflammatory syndrome in children and adolescents with COVID-19. Geneve: World Health Organization, 2020. https://www.who.int/publications-detail/multisystem-inflammatory-syndrome-in-children-and-adolescents-with-covid-19 Lest 26.5.2020.
- 10.
Centers for Disease Control and Prevention. Multisystem Inflammatory Syndrome in Children (MIS-C). https://www.cdc.gov/mis-c/cases/index.html Lest 30.7.2020.
- 11.
Rojahn AE, Gammelsrud KW, Brunvand LI et al. Multiorgan inflammatorisk syndrom assosiert med sars-CoV-2 hos et barn. Tidsskr Nor Legeforen 2020; 140. doi: 10.4045/tidsskr.20.0485. [PubMed][CrossRef]
- 12.
Whittaker E, Bamford A, Kenny J et al. Clinical characteristics of 58 children with a pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2. JAMA 2020; 324: 259–69. [PubMed][CrossRef]
- 13.
Godfred-Cato S, Bryant B, Leung J et al. COVID-19–associated multisystem inflammatory syndrome in children — United States, March–July 2020. MMWR Morb Mortal Wkly Rep 2020; 69: 1074–80. [PubMed][CrossRef]
- 14.
Feldstein LR, Tenforde MW, Friedman KG et al. Characteristics and outcomes of US children and adolescents with multisystem inflammatory syndrome in children (MIS-C) compared with severe acute COVID-19. JAMA 2021; 325: 1074–87. [PubMed][CrossRef]
- 15.
Feldstein LR, Rose EB, Horwitz SM et al. Multisystem inflammatory syndrome in U.S. children and adolescents. N Engl J Med 2020; 383: 334–46. [PubMed][CrossRef]
- 16.
Dufort EM, Koumans EH, Chow EJ et al. Multisystem inflammatory syndrome in children in New York state. N Engl J Med 2020; 383: 347–58. [PubMed][CrossRef]
- 17.
Pediatriveiledere fra Norsk barnelegeforening. https://www.helsebiblioteket.no/retningslinjer/pediatri/revmatologi-ortopedi/multiorgan-inflammatorisk-syndrom-assosiert-med-covid-19 Lest 1.9.2021.
- 18.
Belot A, Antona D, Renolleau S et al. SARS-CoV-2-related paediatric inflammatory multisystem syndrome, an epidemiological study, France, 1 March to 17 May 2020. Euro Surveill 2020; 25: 2001010. [PubMed][CrossRef]
- 19.
Belay ED, Abrams J, Oster ME et al. Trends in geographic and temporal distribution of US children with multisystem inflammatory syndrome during the COVID-19 pandemic. JAMA Pediatr 2021; 175: 837–45. [PubMed][CrossRef]
- 20.
Payne AB, Gilani Z, Godfred-Cato S et al. Incidence of multisystem inflammatory syndrome in children among US persons infected with SARS-CoV-2. JAMA Netw Open 2021; 4: e2116420. [PubMed][CrossRef]
- 21.
Holm M, Hartling UB, Schmidt LS et al. Multisystem inflammatory syndrome in children occurred in one of four thousand children with severe acute respiratory syndrome coronavirus 2. Acta Paediatr 2021; 110: 2581–3. [PubMed][CrossRef]
- 22.
Abrams JY, Oster ME, Godfred-Cato SE et al. Factors linked to severe outcomes in multisystem inflammatory syndrome in children (MIS-C) in the USA: a retrospective surveillance study. Lancet Child Adolesc Health 2021; 5: 323–31. [PubMed][CrossRef]
- 23.
Goyal MK, Simpson JN, Boyle MD et al. Racial and/or ethnic and socioeconomic disparities of SARS-CoV-2 infection among children. Pediatrics 2020; 146: e2020009951. [PubMed][CrossRef]
- 24.
Makino N, Nakamura Y, Yashiro M et al. Epidemiological observations of Kawasaki disease in Japan, 2013-2014. Pediatr Int 2018; 60: 581–7. [PubMed][CrossRef]
- 25.
Kim GB. Reality of Kawasaki disease epidemiology. Korean J Pediatr 2019; 62: 292–6. [PubMed][CrossRef]
- 26.
Kim H, Shim JY, Ko JH et al. Multisystem inflammatory syndrome in children related to COVID-19: the first case in Korea. J Korean Med Sci 2020; 35: e391. [PubMed][CrossRef]
- 27.
Hameed S, Elbaaly H, Reid CEL et al. Spectrum of imaging findings on chest radiographs, US, CT, and MRI images in multisystem inflammatory syndrome in children (MIS-C) associated with COVID-19. Radiology 2021; 298: E1–10. [PubMed][CrossRef]
- 28.
Henderson LA, Yeung RSM. MIS-C: early lessons from immune profiling. Nat Rev Rheumatol 2021; 17: 75–6. [PubMed][CrossRef]
- 29.
Diorio C, Henrickson SE, Vella LA et al. Multisystem inflammatory syndrome in children and COVID-19 are distinct presentations of SARS-CoV-2. J Clin Invest 2020; 130: 5967–75. [PubMed][CrossRef]
- 30.
Henderson LA, Canna SW, Friedman KG et al. American College of Rheumatology Clinical Guidance for multisystem inflammatory syndrome in children associated with SARS–CoV‐2 and hyperinflammation in pediatric COVID‐19: Version 2. Arthritis Rheumatol 2021; 73: e13–29. [PubMed][CrossRef]
- 31.
Kache S, Chisti MJ, Gumbo F et al. COVID-19 PICU guidelines: for high- and limited-resource settings. Pediatr Res 2020; 88: 705–16. [PubMed][CrossRef]
- 32.
Harwood R, Allin B, Jones CE et al. A national consensus management pathway for paediatric inflammatory multisystem syndrome temporally associated with COVID-19 (PIMS-TS): results of a national Delphi process. Lancet Child Adolesc Health 2021; 5: 133–41. [PubMed][CrossRef]
- 33.
Ouldali N, Toubiana J, Antona D et al. Association of intravenous immunoglobulins plus methylprednisolone vs immunoglobulins alone with course of fever in multisystem inflammatory syndrome in children. JAMA 2021; 325: 855–64. [PubMed][CrossRef]
- 34.
Son MBF, Murray N, Friedman K et al. Multisystem inflammatory syndrome in children — Initial therapy and outcomes. N Engl J Med 2021; 385: 23–34. [PubMed][CrossRef]
- 35.
McArdle AJ, Vito O, Patel H et al. Treatment of multisystem inflammatory syndrome in children. N Engl J Med 2021; 385: 11–22. [PubMed][CrossRef]
- 36.
Valverde I, Singh Y, Sanchez-de-Toledo J et al. Acute cardiovascular manifestations in 286 children with multisystem inflammatory syndrome associated with COVID-19 infection in Europe. Circulation 2021; 143: 21–32. [PubMed][CrossRef]
- 37.
Penner J, Abdel-Mannan O, Grant K et al. 6-month multidisciplinary follow-up and outcomes of patients with paediatric inflammatory multisystem syndrome (PIMS-TS) at a UK tertiary paediatric hospital: a retrospective cohort study. Lancet Child Adolesc Health 2021; 5: 473–82. [PubMed][CrossRef]